2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Poster Session

[P71] Poster Session 71 Cross-sectional Program(Miscellaneous)

[P71] Study on optimal starting dose of sunitinib for patients with imatinib-resistant or imatinib-intolerant GIST

Kenta Sasaki1,2, Yoshifumi Matsumoto2, Tatsuo Kanda3, Takashi Ishikawa4, Takuro Saiki2, Qiliang Zhou2, Masato Moriyama2, Yasuo Saijo2 (1.Department of Internal Medicine, Sanjo General Hospital, 2.Department of Medical Oncology, Niigata University Graduate School of Medical and Dental Sciences, 3.Department of Surgery, Sanjo General Hospital, 4.Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password